Andrew McLachlan
Andrew McLachlan receives research funding from the NHMRC, research scholarship funding from GSK for a PhD student under his supervision and has previously received (and disclosed) in kind research support from Pfizer and GSK for investigator initiated research projects. Andrew serves and is paid as an expert on Australian government committees related to medicines regulation and anti-doping.